PetaGene Overview

  • Founded
  • 2010
  • Status
  • Private
  • Employees
  • 11
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $2.1M
Latest Deal Amount
  • Investors
  • 10

PetaGene General Information


Developer of a genetic data compression platform intended to compress huge amounts of genomic data without compromising data quality. The company's platform addresses challenges caused by growing volumes of genomics data and transparently integrates it with existing storage infrastructure and bioinformatics pipelines, enabling researchers to analyze genomic data to improve health and medicine for everyone.

Contact Information

Formerly Known As
Project PetaGene
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Business/Productivity Software
Primary Office
  • Betjeman House
  • 104 Hills Road
  • Cambridge CB2 1LQ
  • England, United Kingdom
+44 01223 000000

PetaGene Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PetaGene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 19-Dec-2018 $2.1M 00.000 Completed Generating Revenue
4. Later Stage VC 06-Apr-2017 00.00 00.000 Completed Generating Revenue
3. Accelerator/Incubator 06-Sep-2016 00000 00000 00000 Completed Generating Revenue
2. Grant 22-Aug-2014 $116K Completed Startup
1. Accelerator/Incubator Completed Startup
To view PetaGene’s complete valuation and funding history, request access »

PetaGene Executive Team (3)

Name Title Board Seat Contact Info
Daniel Greenfield Ph.D Co-Founder, Chief Executive Officer & Board Member
Vaughan Wittorff Ph.D Co-Founder & Chief Commercial Officer
You’re viewing 2 of 3 executive team members. Get the full list »

PetaGene Board Members (2)

Name Representing Role Since
Daniel Greenfield Ph.D PetaGene Co-Founder, Chief Executive Officer & Board Member 000 0000
Krishna Gupta Romulus Capital Board Member 000 0000
To view PetaGene’s complete board members history, request access »

PetaGene Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PetaGene Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Samos Investments Venture Capital Minority 000 0000 000000 0
Acequia Capital Venture Capital Minority 000 0000 000000 0
Charles Songhurst Angel (individual) Minority 000 0000 000000 0
Hamad Alhomaizi Angel (individual) Minority 000 0000 000000 0
Nicolas Berggruen Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »